250 mg CK-2017357

DRUG2 trials

Sponsors

Cytokinetics

Conditions

Amyotrophic Lateral SclerosisMyasthenia Gravis

Phase 2

A Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)

CompletedNCT01089010

CytokineticsAmyotrophic Lateral Sclerosis

Start: 2010-03-31End: 2010-11-30Updated: 2019-05-10

Pharmacodynamic Study of CK-2017357 in Patients With Generalized Myasthenia Gravis

TerminatedNCT01268280

CytokineticsMyasthenia Gravis

Start: 2010-12-31End: 2012-10-31Updated: 2019-09-24